BioNTech SE Company Contacts

BioNTech SE

https://biontech.de/
BioNTech is a global next generation immunotherapy company aspiring to translate science into survival. Around 6.100 pioneers currently work with us, employing a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Our... Read More
Contacts

Country

Germany

City

Mainz

Headquarters

Mainz, Rhineland-Palatinate

Profile

Founded

2008

Industry

Biotechnology Research

Size

1001 - 5000

Specialties

Biotechnology, Individualized cancer medicine, Patient-specific immunotherapy, mRNA therapeutics, Cell therapy, Antibody therapeutics, Small molecule immunomodulators, Tailored therapeutics, Immunotherapy, Oncology, CAR T, TCR, Bispecific antibodies, Rare diseases, Infectious diseases

Funding

Total Rounds

10

Last Round

Tue May 28 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 145,000,000